Heparin

  • Description and indication for use

    Heparin is used for systemic anti-coagulation and to manage venous thromboembolism after discussion with a paediatric haematologist. It is also used to maintain central venous catheters and arterial line patency. Heparin has little thrombolytic activity and is generally used to prevent further clot formation.1

    Dose

    For systemic anti-coagulation

    Low dose treatment:

    IV and INF:

    Loading dose 75 units/kg, then 5 to 15 units/kg/hr.  Adjust dose according to clotting times.

    SC:

    75 units/kg 12 hourly.

    Full dose treatment:

    IV and INF: 

    Loading dose 75 units/kg, then 20 - 40 units/kg/hr.  Adjust according to clotting times.

    To maintain patency of umbilical and peripheral arterial lines

    IA:

    Babies with current weight < 2kg: 1 unit/mL (50 units/50 mL) at a rate of 0.5 mL/hr or for peripheral arterial line at 1 mL/hr).

    Babies with current weight ≥ 2kg: 5 units/mL (250 units/50 mL) at a rate of 1 mL/hr.

    To maintain patency of central venous catheter (e.g.: long line) if no parenteral nutrition running

    IV:

    1 unit/mL (50 units/50 mL) at a rate of 0.5 mL/hr or 1 mL/hr.

    NOTE: 1 mg Protamine neutralises approximately 100 units of Heparin.2

    Reconstitution/Dilution

    Heparin Sodium vial = 1000 units/mL, 5000 units/0.2 mL, 5000 units/mL.

    Heparinised saline ampoule = 50 units/5 mL (10 units/mL).

    Solution

    Concentration

    Drug Infusion diluent** How to make up
    As prescribed

    Heparin Sodium

    Use 1000 units/mL or 5000 units/mL

    Sodium Chloride 0.9%

    Add 500 units/kg to 50 mL syringe Sodium Chloride 0.9%.

    1 mL/hr = 10 u/kg/hr

    Dose range 10-40 units/kg/hour

    (1 mL/hr = 10 units/kg/hr)

    1unit/mL

    Heparinised saline

    Use 50 units/5 mL

    Sodium Chloride 0.45%

    Add 50 units (5 mL) to a 50 mL syringe

    and make up to 50 mL

    5 units/mL

    Heparin Sodium

    Use 1000 units/mL

    Sodium Chloride 0.9% Add 2500 units (2.5 mL) to 500 mL bag, withdraw 50mL of final solution into 50mL syringe.

    Route and method of administration

    IA and IV infusion:

    Give as a continuous infusion at the prescribed rate via syringe pump.

    Prime Line: Use Minimum Volume Extension tubing (Volume = 1 mL) prime line with preloaded syringe containing exact dose of Heparin.

    Side effects

    Bleeding, bruising, thrombocytopaenia (rare), urticarial.

    Nursing responsibilities

    Observe infant for bleeding or bruising.

    Monitor IV site for extravasation.

    Heparin is incompatible with many medicines. Please flush line with Sodium Chloride 0.9% before giving other medicines.

    Compatibility information

    IMPORTANT: Contact pharmacy for drugs not appearing in the table below. Uncommon drugs have simply been omitted and may be incompatible.

      Compatible Incompatible  
    Fluids Glucose 5%, Glucose 10%, Glucose 25%, Sodium Chloride 0.45%, Sodium Chloride 0.9%    
    Drugs Benzylpenicillin, Calcium Gluconate, Dopamine, Flucloxacillin, Fluconazole, Frusemide, Magnesium Sulphate, Noradrenaline, Potassium Chloride, Ranitidine, Sodium Bicarbonate Amikacin, Amiodarone Diazepam, Dobutamine, Gentamicin, Phenytoin, Vancomycin  
    Y-Site Aciclovir, Adrenaline, Atropine, Caffeine Citrate5, Fentanyl, Hydrocortisone Sodium Succinate, Insulin (Neutral), Meropenem, Metronidazole, Midazolam, Morphine Sulphate, Pancuronium, Phenobarbitone, Suxamethonium, Vecuronium, Zidovudine.  

    Reference:

    1.    Neonatal Formulary: Drug use in pregnancy and the first year of life, 5th ed. 2007.
    2.    RCH Paediatric Pharmacopoeia, 13th ed. 2002.
    3.    Australian Injectables Handbook, SHPA, 5th ed. 2011.
    4.    Lawrence Trissel, Handbook on Injectable Drugs, 17th ed. 2013.
    5.    Thomas Young et al. Neofax, 22nd ed. 2009.
    6.    RWH Neonatal Pharmacopoeia, 2nd ed. 2005.
    7.    Cloherty J.P, Eichenwald E.C, Stark A.R. Manual of Neonatal Care, 6th ed. 2008.
    8.    British National Formulary for Children, 2013 – 2014.
    9.    Frank Shann, Drug Doses, RCH, 15th ed. 2010.






Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for